MAXIDEX

Main information

  • Trade name:
  • MAXIDEX Eye ointment 1MG/G
  • Dosage:
  • 1MG/G
  • Pharmaceutical form:
  • Eye ointment
  • Administration route:
  • Ocular use
  • Units in package:
  • 1X3,5G Tube
  • Prescription type:
  • with prescription
  • Medicine domain:
  • Humans
  • Medicine type:
  • Allopathic drug

Documents

Localization

  • Available in:
  • MAXIDEX Eye ointment 1MG/G
    Czech Republic
  • Language:
  • English

Therapeutic information

  • Therapeutic area:
  • DEXAMETHASONE
  • Product summary:
  • MAXIDEX

Other information

Status

  • Source:
  • SUKL - Státní ústav pro kontrolu léčiv
  • Authorization number:
  • F - specific therapeutic programme
  • Last update:
  • 05-04-2018

22-11-2018

Ozurdex (Allergan Pharmaceuticals Ireland)

Ozurdex (Allergan Pharmaceuticals Ireland)

Ozurdex (Active substance: dexamethasone) - PSUSA - Modification - Commission Decision (2018)7886 of Thu, 22 Nov 2018 European Medicines Agency (EMA) procedure number: EMEA/H/C/1140/PSUSA/985/201801

Europe -DG Health and Food Safety

24-9-2018

Neofordex (Laboratoires CTRS)

Neofordex (Laboratoires CTRS)

Neofordex (Active substance: dexamethasone) - Centralised - Yearly update - Commission Decision (2018)6239 of Mon, 24 Sep 2018

Europe -DG Health and Food Safety